Literature DB >> 23039636

Segmentation of malignant gliomas through remote collaboration and statistical fusion.

Zhoubing Xu1, Andrew J Asman, Eesha Singh, Lola Chambless, Reid Thompson, Bennett A Landman.   

Abstract

PURPOSE: Malignant gliomas represent an aggressive class of central nervous system neoplasms. Correlation of interventional outcomes with tumor morphometry data necessitates 3D segmentation of tumors (typically based on magnetic resonance imaging). Expert delineation is the long-held gold standard for tumor segmentation, but is exceptionally resource intensive and subject to intrarater and inter-rater variability. Automated tumor segmentation algorithms have been demonstrated for a variety of imaging modalities and tumor phenotypes, but translation of these methods across clinical study designs is problematic given variation in image acquisition, tumor characteristics, segmentation objectives, and validation criteria. Herein, the authors demonstrate an alternative approach for high-throughput tumor segmentation using Internet-based, collaborative labeling.
METHODS: In a study of 85 human raters and 98 tumor patients, raters were recruited from a general university campus population (i.e., no specific medical knowledge), given minimal training, and provided web-based tools to label MRI images based on 2D cross sections. The labeling goal was characterized as to extract the enhanced tumor cores on T1-weighted MRI and the bright abnormality on T2-weighted MRI. An experienced rater manually constructed the ground truth volumes of a randomly sampled subcohort of 48 tumor subjects (for both T1w and T2w). Raters' taskwise individual observations, as well as the volume wise truth estimates via statistical fusion method, were evaluated over the subjects having the ground truth.
RESULTS: Individual raters were able to reliably characterize (with >0.8 dice similarity coefficient, DSC) the gadolinium-enhancing cores and extent of the edematous areas only slightly more than half of the time. Yet, human raters were efficient in terms of providing these highly variable segmentations (less than 20 s per slice). When statistical fusion was used to combine the results of seven raters per slice for all slices in the datasets, the 3D agreement of the fused results with expertly delineated segmentations was on par with the inter-rater reliability observed between experienced raters using traditional 3D tools (approximately 0.85 DSC). The cumulative time spent per tumor patient with the collaborative approach was equivalent to that with an experienced rater, but the collaborative approach could be achieved with less training time, fewer resources, and efficient parallelization.
CONCLUSIONS: Hence, collaborative labeling is a promising technique with potentially wide applicability to cost-effective manual labeling of medical images.

Entities:  

Mesh:

Year:  2012        PMID: 23039636      PMCID: PMC3461053          DOI: 10.1118/1.4749967

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  20 in total

1.  Extent of resection in malignant gliomas: a critical summary.

Authors:  R Sawaya
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

2.  Multi-parametric neuroimaging reproducibility: a 3-T resource study.

Authors:  Bennett A Landman; Alan J Huang; Aliya Gifford; Deepti S Vikram; Issel Anne L Lim; Jonathan A D Farrell; John A Bogovic; Jun Hua; Min Chen; Samson Jarso; Seth A Smith; Suresh Joel; Susumu Mori; James J Pekar; Peter B Barker; Jerry L Prince; Peter C M van Zijl
Journal:  Neuroimage       Date:  2010-11-20       Impact factor: 6.556

3.  Robust statistical fusion of image labels.

Authors:  Bennett A Landman; Andrew J Asman; Andrew G Scoggins; John A Bogovic; Fangxu Xing; Jerry L Prince
Journal:  IEEE Trans Med Imaging       Date:  2011-10-14       Impact factor: 10.048

4.  COLLABORATIVE LABELING OF MALIGNANT GLIOMA.

Authors:  Zhoubing Xu; Andrew J Asman; Eesha Singh; Lola Chambless; Reid Thompson; Bennett A Landman
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2012-12-31

5.  Fully automated tumor segmentation based on improved fuzzy connectedness algorithm in brain MR images.

Authors:  Vida Harati; Rasoul Khayati; Abdolreza Farzan
Journal:  Comput Biol Med       Date:  2011-05-23       Impact factor: 4.589

6.  Tumour volume determination from MR images by morphological segmentation.

Authors:  P Gibbs; D L Buckley; S J Blackband; A Horsman
Journal:  Phys Med Biol       Date:  1996-11       Impact factor: 3.609

7.  Comparison of supervised MRI segmentation methods for tumor volume determination during therapy.

Authors:  M Vaidyanathan; L P Clarke; R P Velthuizen; S Phuphanich; A M Bensaid; L O Hall; J C Bezdek; H Greenberg; A Trotti; M Silbiger
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

8.  Characterizing and Optimizing Rater Performance for Internet-based Collaborative Labeling.

Authors:  Joshua A Stein; Andrew J Asman; Bennett A Landman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-03-03

9.  Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering.

Authors:  Kyrre E Emblem; Baard Nedregaard; John K Hald; Terje Nome; Paulina Due-Tonnessen; Atle Bjornerud
Journal:  J Magn Reson Imaging       Date:  2009-07       Impact factor: 4.813

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  1 in total

1.  A low-interaction automatic 3D liver segmentation method using computed tomography for selective internal radiation therapy.

Authors:  Mohammed Goryawala; Seza Gulec; Ruchir Bhatt; Anthony J McGoron; Malek Adjouadi
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.